BIG
PGEN icon

Brooklyn Investment Group’s Precigen PGEN Stock Holding History

Brooklyn Investment Group’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-502
Closed -$713 – 2114
2025
Q2 		$713 Buy
+502
New +$713 ﹤0.01% 3015

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Brooklyn Investment Group's PGEN Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Precigen (PGEN) in Q3 2025, closing a stake of 502 shares — an estimated $713 sold.

Brooklyn Investment Group first reported a position in PGEN in Q2 2025 and held it in 1 quarter. The position peaked at $713 in Q2 2025. 167 funds tracked by Wall St. Rank hold PGEN as of Q3 2025.

  • Brooklyn Investment Group reported no remaining Precigen position as of Q3 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 502 Precigen shares in Q3 2025, an estimated $713.
  • Brooklyn Investment Group first reported a position in Precigen in Q2 2025 and held it in 1 quarter.
  • Brooklyn Investment Group's Precigen position peaked at $713 in Q2 2025.
  • 167 funds tracked by Wall St. Rank held Precigen as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.